Back to top

Welcome to MS Australia

News

The Pharmaceutical Benefits Advisory Committee (PBAC) announced at 4pm today (20/4/18), they have not recommended the listing of MAVENCLAD® (cladribine tablets) for relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).

The PBAC said that it, “did not recommend the listing of cladribine for the treatment of relapsing remitting multiple sclerosis (RRMS), on the basis of uncertainty in the non-inferior efficacy claim...

Blog

Unlike most diagnoses of Multiple Sclerosis 24 hours was all it took to receive my diagnosis and, what's more, it was me that asked to be tested specifically for MSIt was November 1997 when I went off to see a neurologist. I had been booked in to see the specialist following a car accident with a semi-trailer which resulted in me suffering whiplash. "Whilst I am here,” I said to the specialist, “can you also test me for Multiple Sclerosis?" With that he frowned at me and asked me why I thought...

Events

Walk and Run

MS Walk + Fun Run: Sydney

Sunday 29th April
Starts & finishes at Metcalfe Park
New South Wales

Tweets by @MS_Australia

Support & Services

As the national peak body for Australians living with MS, we work closely with the state MS societies to help you connect with the right support and services.

 

Support & Services